Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B

Chronic hepatitis B (CHB) virus continues to be a leading cause of morbidity and mortality worldwide. The diagnosis of liver fibrosis has a key role in selecting patients with CHB for antiviral treatment. However, serum biomarkers demonstrate limited diagnostic utility. The present study aimed to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Yuki, Namisaki, Tadashi, Kaji, Kosuke, Takaya, Hiroaki, Nakanishi, Keisuke, Sato, Shinya, Saikawa, Soichiro, Sawada, Yasuhiko, Kitagawa, Kou, Shimozato, Naotaka, Kawaratani, Hideto, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388477/
https://www.ncbi.nlm.nih.gov/pubmed/32765655
http://dx.doi.org/10.3892/etm.2020.8798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388477/
https://www.ncbi.nlm.nih.gov/pubmed/32765655
http://dx.doi.org/10.3892/etm.2020.8798

Ejemplares similares